12/01/1997
https://www.congress.gov...
We should also use this as an opportunity to review the procedures at the United States Patent and Trademark Office.
Professor Blinder, your testimony attracted three questions from me.
The committee has received a letter from over 65 advocacy organizations opposing the bill.
I support the idea of making prescription drugs affordable and accessible for all Americans, for everybody.